We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · January 13, 2022

Glucose Control Outcomes With a Long-Term Implantable CGM System in Type 1 Diabetes Prone to Hypoglycemia

Diabetes, Obesity & Metabolism

 

Additional Info

Diabetes, Obesity & Metabolism
Reduction of clinically important low glucose excursions with a long-term implantable continuous glucose monitoring (CGM) system in adults with type 1 diabetes prone to hypoglycemia. France Adoption randomized clinical trial
Diabetes Obes Metab 2022 Jan 04;[EPub Ahead of Print], E Renard, JP Riveline, H Hanaire, B Guerci

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading